1-(tert-butyloxy)carbonyl-spiro[piperidine-4,3'-indane]-5'-carboxaldehyde | 1025688-00-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 茚和异茚
• 英文名称: 1-(tert-butyloxy)carbonyl-spiro[piperidine-4,3'-indane]-5'-carboxaldehyde
• 英文别名: Tert-butyl 6-formylspiro[indene-1,4'-piperidine]-1'-carboxylate
• CAS: 1025688-00-9
• 化学式: C₁₉H₂₃NO₃
• 分子量: 313.397
• InChiKey: MDKOWOIHKLQIBM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  23
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.47
• 拓扑面积：
  46.6
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-(tert-butyloxy)carbonyl-spiro[piperidine-4,3'-indane]-5'-carboxaldehyde 在 肼 作用下， 以 乙醇 为溶剂， 生成 C₁₉H₂₅N₃O₂
  参考文献：
  名称：

  Potent, nonpeptide inhibitors of human mast cell tryptase. Synthesis and biological evaluation of novel spirocyclic piperidine amide derivatives

  摘要：

  We have explored a series of spirocyclic piperidine amide derivatives ( 5) as tryptase inhibitors. Thus, 4 (JNJ-27390467) was identified as a potent, selective tryptase inhibitor with oral efficacy in two animal models of airway inflammation ( sheep and guinea pig asthma models). An X-ray co-crystal structure of 4 tryptase revealed a hydrophobic pocket in the enzyme's active site, which is induced by the phenylethynyl group and is comprised of amino acid residues from two different monomers of the tetrameric protein. (c) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.01.093
• 作为产物：
  描述：

  一氧化碳 、 6-溴螺[茚-1,4-哌啶]-1-羧酸叔丁酯 在 反式双(三苯基膦)二氯溴钯(II) sodium formate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 以51%的产率得到1-(tert-butyloxy)carbonyl-spiro[piperidine-4,3'-indane]-5'-carboxaldehyde
  参考文献：
  名称：

  Potent, nonpeptide inhibitors of human mast cell tryptase. Synthesis and biological evaluation of novel spirocyclic piperidine amide derivatives

  摘要：

  We have explored a series of spirocyclic piperidine amide derivatives ( 5) as tryptase inhibitors. Thus, 4 (JNJ-27390467) was identified as a potent, selective tryptase inhibitor with oral efficacy in two animal models of airway inflammation ( sheep and guinea pig asthma models). An X-ray co-crystal structure of 4 tryptase revealed a hydrophobic pocket in the enzyme's active site, which is induced by the phenylethynyl group and is comprised of amino acid residues from two different monomers of the tetrameric protein. (c) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.01.093

文献信息

• [EN] SPIROPIPERIDINES FOR USE AS TRYPTASE INHIBITORS<br/>[FR] SPIROPIPÉRIDINES UTILISABLES EN TANT QU'INHIBITEURS DE LA TRYPTASE
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2009067202A1

  公开（公告）日：2009-05-28

  The present invention is directed to a compound of Formula (I): (I) or a form thereof, wherein X1, X2, X3, X4, R1, R2 and R3 are as defined herein, useful as tryptase inhibitors.

  本发明涉及一种化合物，其化学式为（I）：（I）或其形式，其中X1、X2、X3、X4、R1、R2和R3如本文所定义，可用作色氨酸蛋白酶抑制剂。
• SPIROPIPERIDINES FOR USE AS TRYPTASE INHIBITORS
  申请人：Costanzo Michael J.

  公开号：US20120165327A1

  公开（公告）日：2012-06-28

  The present invention is directed to a compound of Formula (I): or a form thereof, wherein X 1 , X 2 , X 3 , X 4 , R 1 , R 2 and R 3 are as defined herein, useful as tryptase inhibitors.

  本发明涉及一个公式(I)的化合物或其形式，其中X1，X2，X3，X4，R1，R2和R3如本文所定义，可用作组胺酶抑制剂。
• Spiropiperidines for use as tryptase inhibitors
  申请人：Costanzo Michael J.

  公开号：US20090163527A1

  公开（公告）日：2009-06-25

  The present invention is directed to a compound of Formula (I): or a form thereof, wherein X 1 , X 2 , X 3 , X 4 , R 1 , R 2 and R 3 are as defined herein, useful as tryptase inhibitors.

  本发明涉及一种化合物，其化学式为(I)或其形式，其中X1、X2、X3、X4、R1、R2和R3的定义如本文所述，用作胰蛋白酶抑制剂。
• US8158792B2
  申请人：——

  公开号：US8158792B2

  公开（公告）日：2012-04-17
• US8536189B2
  申请人：——

  公开号：US8536189B2

  公开（公告）日：2013-09-17